NR3C1 and demyelinating disease: As promising strategies in demyelinating diseases, it is worth mentioning the agonism of GABAA [10] and GABAB [11], the activation of metabotropic glutamate receptors (mGluRs) [12,13], the antagonism of muscarinic acetylcholine receptors (mAchRs) [14], or the activation of glucocorticoid receptors [15].